Morgan Lewis

Life Sciences Publications of Interest

For More Information

Life Sciences Deskbook

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Fast Facts

200 partners and counsel focused on the life sciences industry

60 professionals with advanced scientific degrees

800 active life sciences clients

Honors

PLCCross-border Quarterly 2009 Life Sciences Legal Market Review

  • Industry Super League - Ranked 16th among law firms worldwide
  • Regulatory Super League - Ranked 7th among law firms worldwide

PLCCross-border Life Sciences Handbook 2007/2008

  • U.S. - Recognized for commercial/ partnering, competition/ antitrust, corporate, government law enforcement/ investigations, regulatory, regulatory/ medical devices, and patent counseling
  • England - Recognized for regulatory
  • Japan - Recognized for corporate/commercial

Chambers USA 2010: Recommended in Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory

UK Legal 500 2007/2008: London: Pharmaceuticals and Biotechnology

BioPharm Insight 2010

  • Global Legal Advisers to Licensing Agreements: Value - Ranked third
  • Global Legal Advisers to Licensing Agreements: Volume - Ranked  fourth 
  • Legal Advisers to North American Licensing Agreements: Value - Ranked third 
  • Legal Advisers to North American Licensing Agreements: Volume - Ranked third 
  • Legal Advisers to European Licensing Agreements: Value - Ranked third 
  • Legal Advisers to European Licensing Agreements: Volume - Ranked fifth

Clients

16 of the top 20 pharmaceutical companies

7 of the top 20 biotechnology companies

12 of the top 20 medical device companies

153 Publications Found
page 1 of 9
07/06/10 Price Reporting and Governmental Rebate Issues Arising from the Healthcare Reform Law—an Early Assessment

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Andrew Ruskin

With the passage of the Patient Protection and Affordable Care Act (the Healthcare Reform Law) three months ago, pharmaceutical manufacturers are continuing to assess how the changes to their price-reporting responsibilities are ... more

May/June 2010 Square Peg in a Round Hole: Two Recent Cases Show Potential Limitations for States in AWP Litigation, Journal of Health Care Compliance

Outside Publication | Article
Kashmira Makwana

05/24/10 Treasury Issues Guidance for 50% Tax Credit/Cash Grant for Life Sciences Companies

LawFlash/Client Alert | Tax LawFlash
Wendy Unglaub, Gary Wilcox

On May 21, 2010, the U.S. Department of the Treasury (Treasury) issued Notice 2010-45 (the Guidance), which outlines the procedures for obtaining a valuable new 50% tax credit or equivalent cash grant for certain companies in t... more

05/11/10 Life Sciences Mergers and Acquisitions: How Healthcare Reform Will Change Your Partnership Strategy, presented at a Elsevier Business Intelligence Webinar

Presentation | Speech
Stephen Mahinka, Joyce Cowan

05/11/10 Life Sciences Real Estate in New Jersey Webcast

Presentation | Webcast
John McAleese, III, J.J. Broderick

05/05/10 Beyond the Border & Beyond the Boundary, presented at the 2010 BioInternational Convention, Chicago

Presentation | Speech
Wenseng Pan, Ph.D.

04/27/10 Healthcare Reform Law and Mandatory Compliance Programs

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Scott Memmott, Howard Young

With the passage of the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care Education Reconciliation Act of 2010 (the Healthcare Reform Law), Congress for the first time has mandated that a broad r... more

04/21/10 New 50% Tax Credit/Cash Grant for Life Science Companies Requires Timely Determination of Eligibility and Application

LawFlash/Client Alert | Tax LawFlash
Wendy Unglaub, Gary Wilcox

The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), provides for a valuable new 50% tax credit or equivalent cash grant, fo... more

04/19/10 Healthcare Reform Law: Comparative Effectiveness Provisions Concerning Healthcare Products and Services

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Stephen Mahinka

The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), contains provisions supporting the development of comparative effectiven... more

04/15/10 Healthcare Reform Law: A New Regulatory Pathway for Biosimilar Biological Products

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Kathleen Sanzo, Phoebe Mounts

The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), establishes an abbreviated licensure pathway for biosimilar biological p... more

04/15/10 Healthcare Reform Law: Impact on Pharmaceutical Manufacturers

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Kathleen Sanzo

The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law, or Law), will have a number of direct and indirect effects on pharmaceutic... more

04/14/10 Healthcare Reform Law Leads to Significant Changes to the 340B Program

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Washington Government Relations and Public Policy Practice

The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law, or Law), provides for a number of significant revisions to the existing 34... more

04/14/10 Immediate Healthcare Reform Law Issues for Group Health Plans Come Into Sharper Focus

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Riva Johnson, Saghi Fattahian, Andy Anderson

The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), creates a number of immediate issues for employer group health plans. Some o... more

04/13/10 Healthcare Reform Law Imposes New Tax and Other Requirements for Device Manufacturers

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
M. Elizabeth Bierman, Michele Buenafe

The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), presents a number of new issues for medical device manufacturers. Devic... more

04/13/10 Healthcare Reform Law: Issues Affecting Hospitals and Health Systems

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Andrew Ruskin, Albert Shay

The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), includes substantial changes that will affect how hospitals of all type... more

04/09/10 Healthcare Reform Law Cuts Medicare Advantage Payments and (Mostly) Increases Prescription Drug Program Payments

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Kashmira Makwana, Joyce Cowan

The Patient Protection and Affordable Care Act of 2010 as amended by the Health Care and Education Reconciliation Act of 2010 (Healthcare Reform Law) makes substantial changes to the Medicare Part C Medicare Advantage (MA) and Me... more

04/07/10 Healthcare Reform Law Requires Reasonable Break Times and Locations for Nursing Mothers

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Michael Ossip, Sarah Andrews

The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), includes a provision that requires employers to provide covered employe... more

04/01/10 FDA Proposed Rule Requires Reporting Suspected Falsification of Data in Studies with Human or Animal Subjects

LawFlash/Client Alert | FDA and Healthcare LawFlash
FDA and Healthcare Practice

The U.S. Food and Drug Administration (FDA or the Agency) recently announced a Proposed Rule titled “Reporting Information Regarding Falsification of Data” in a February 19 Federal Register Notice (75 Fed. Reg. 7,41... more

03/31/10 Healthcare Reform Law: Healthcare Fraud and Abuse and Program Integrity Provisions

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Kathleen McDermott, Meredith Auten

The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), contains more than 32 sections related to healthcare fraud and abuse an... more

03/31/10 U.S. District Court Invalidates Patents Claiming BRCA Genes

LawFlash/Client Alert | Intellectual Property LawFlash
Intellectual Property Practice

On March 29, a U.S. District Court sided with the American Civil Liberties Union (ACLU) and other plaintiffs in an ongoing lawsuit, declaring Myriad Genetics’ patents directed toward nucleotides encoding BRCA genes as inva... more

03/29/10 Healthcare Reform Law Delivers New Transparency Requirements for the Health Industry

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Kathleen McDermott

The Patient Protection and Affordable Care Act of 2010 as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law) provides for a number of new transparency requirements for several health ... more

03/25/10 Healthcare Reform Law and Its Impact on Business: Ongoing Information and Analysis from Morgan Lewis

LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Washington Government Relations and Public Policy Practice

The Patient Protection and Affordable Care Act (the Healthcare Reform Law) that President Obama signed into law on March 23 contains a large number of provisions that will significantly affect businesses in the coming months and... more

November/December 2009 21st Century Toxicology and its Implications for FDA Regulation of Food-Contact Substances, FDLI Update

Outside Publication | Article
Stephen Mahinka

11/16/09 Battle Weary Life Sciences Industry Put on Notice

LawFlash/Client Alert | Foreign Corrupt Practices Act LawFlash
Amy Conway-Hatcher

On November 12, the Justice Department’s Assistant Attorney General for the Criminal Division, Lanny Breuer, issued a stern warning to the life sciences industry and its executives. As the country wrestles with the challe... more

10/27/09 Funding Healthcare and IT Media, presented at the 2009 New York Life Sciences & Healthcare Venture Summit

Presentation | Speech
Emilio Ragosa

page 1 of 9